Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: A meta-analysis

Tumor Biology

Volumn 34, Issue 2, 2013, Pages 1255-1262

  Yao, Fan ^a   Fang, Yue ^a   Chen, Bo ^a   Jin, Feng ^a   Wang, Shubao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; NBS1 Glu185Gln; Polymorphism

Indexed keywords

GLUTAMINE; GLYCINE; CELL CYCLE PROTEIN; NBN PROTEIN, HUMAN; NUCLEAR PROTEIN;

AFRICAN; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CAUCASIAN; DNA POLYMORPHISM; ETHNIC GROUP; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; NBS1 GENE; ONCOGENE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS;

MLCS; MLOWN;

EID: 84877108475     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0668-4     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000;321:624-8.
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66-71.
4. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789-92.
5. Zhou LP, Luan H, Dong XH, Jin GJ, Ma DL, et al. Association of functional polymorphisms of the XRCC4 gene with the risk of breast cancer: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:3431-6.
6. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007;39:165-7.
7. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006;38:873-5.
8. Matsuura S, Tauchi H, Nakamura A, Kondo N, Sakamoto S, et al. Positional cloning of the gene for Nijmegen breakage syndrome. Nat Genet. 1998;19:179-81.
9. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 1998;93:467-76.
10. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26:1263-71.
11. Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, et al. Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis. 2010;31:1264-71.
12. Cerosaletti KM, Morrison VA, Sabath DE, Willerford DM, Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer. 2002;35:282-6.
13. Lu M, Lu J, Yang X, Yang M, Tan H, et al. Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis. BMC Cancer. 2009;9:124.
14. Huang MD, Chen XF, Xu G, Wu QQ, Zhang JH, et al. Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population. DNA Cell Biol. 2012;31:678-82.
15. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256-66.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
19. Tobias A, Saez M, Galan I, Campbell MJ. Sensitivity analysis of common statistical models used to study the short-term effects of air pollution on health. Int J Biometeorol. 2003;47:227-9.
20. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 470-461.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
22. Desjardins S, Beauparlant JC, Labrie Y, Ouellette G, Durocher F. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer. BMC Cancer. 2009;9:181.
23. Forsti A, Angelini S, Festa F, Sanyal S, Zhang Z, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep. 2004;11:917-22.
24. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, et al. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010;51:343-52.
25. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet. 2002;11:1399-407.
26. Loizidou MA, Cariolou MA, Neuhausen SL, Newbold RF, Bashiardes E, et al. Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population. Breast Cancer Res Treat. 2010;121:147-56.
27. Lu J, Wei Q, Bondy ML, Li D, Brewster A, et al. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women < or = 55 years. Carcinogenesis. 2006;27:2209-16.
28. Millikan RC, Player JS, Decotret AR, Tse CK, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:2326-34.
29. Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, et al. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol. 2010;34:85-92.
30. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis. 2008;29:2132-8.
31. Zhang L, Zhang Z, Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta. 2005;359:150-5.
32. Antoccia A, Kobayashi J, Tauchi H, Matsuura S, Komatsu K. Nijmegen breakage syndrome and functions of the responsible protein, NBS1. Genome Dyn. 2006;1:191-205.
33. Matsuura S, Kobayashi J, Tauchi H, Komatsu K. Nijmegen breakage syndrome and DNA double strand break repair by NBS1 complex. Adv Biophys. 2004;38:65-80.
34. Vissinga CS, Yeo TC, Warren S, Brawley JV, Phillips J, et al. Nuclear export of NBN is required for normal cellular responses to radiation. Mol Cell Biol. 2009;29:1000-6.
35. Lee JH, Paull TT. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science. 2004;304:93-6.
36. Ryk C, Kumar R, Thirumaran RK, Hou SM. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer. 2006;54:285-92.
37. Jiang L, Liang J, Jiang M, Yu X, Zheng J, et al. Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population. Eur J Haematol. 2011;86:199-205.
38. Singletary SE. Rating the risk factors for breast cancer. Ann Surg. 2003;237:474-82.
39. Gompel A, Santen RJ. Hormone therapy and breast cancer risk 10 years after the WHI. Climacteric. 2012;15:241-9.
40. Griffin JL, Pearlman MD. Breast cancer screening in women at average risk and high risk. Obstet Gynecol. 2010;116:1410-21.